Brief: Radiopharm Theranostics Says ITM Isotope Technologies Munich SE And Co Sign Supply Agreement
19/05/2025 02:37
May 19 (Reuters) - Radiopharm Theranostics Ltd RAD.AX: ITM ISOTOPE TECHNOLOGIES MUNICH SE AND RADIOPHARM SIGN SUPPLY AGREEMENT FOR N.C.A. LUTETIUM-177 Further company coverage: RAD.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Radiopharm Theranostics
See all newsBrief: Radiopharm Theranostics Advances To Cohort 3 In 177Lu-RAD202 Phase 1 Dose Escalating Clinical Trial
Brief: Radiopharm Theranostics And Siemens Healthineers Sign Clinical Supply Agreement For Rad101 In The U.S.
Brief: Radiopharm Theranostics Says RAD And Siemens Sign Clinical Supply Agreement For Rad101
Brief: Radiopharm Theranostics Doses First Patient In Phase 1/2A Clinical Study Of Betabart
Brief: Radiopharm Theranostics Says Co Increases Ownership In Radiopharm Ventures To 87.5%